Nancy Miller-Rich has served as a member of the 4DMT board of directors since November 2020. She has served as a consultant and advisor to various pharmaceutical and biotechnology companies since September 2017.
Previously, Ms. Miller-Rich served in a number of leadership roles at Merck & Co., Inc. and, prior to the merger of the two companies, at Schering-Plough Corporation, including most recently as Senior Vice President, Global Human Health Business Development & Licensing, Strategy and Commercial Support from November 2013 to September 2017 and as Group Vice President, Consumer Care Global New Ventures and Strategic Commercial Development from January 2007 to November 2013. Prior to joining Schering-Plough in 1990, she served in a variety of commercial and marketing roles at Sandoz Pharmaceuticals and Sterling Drug, Inc.
Ms. Miller-Rich received her undergraduate degree in Business Administration, Marketing, from Ithaca College in 1981.